Abstracts

Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings

08/23/2024

Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...

Ibrutinib, acalabrutinib, and...

08/23/2024

Journal of Clinical Pathways

Abstracts

The Impact in Quality of Life of Adverse Events With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States

08/23/2024

Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...

Systemic therapies for...

08/23/2024

Journal of Clinical Pathways

Abstracts

The Economic Impact of Vial Sizes on Drug Waste of Bortezomib and Carfilzomib in Multiple Myeloma: The US Oncology Network Study

08/23/2024

Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...

Drug waste poses a significant...

08/23/2024

Journal of Clinical Pathways

Abstracts

Ready or Not: Assessment of Readiness for Oncology Value-Based Care Program Participation

08/23/2024

Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...

Conducting a thorough and...

08/23/2024

Journal of Clinical Pathways

Abstracts

Beyond the Diagnosis: Exploring the Multifaceted Distress Proﬁle of Patients With Cancer

08/23/2024

To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....

To fully understand and rectify...

08/23/2024

Journal of Clinical Pathways

Abstracts

A Pilot Program of Automated Patient Identiﬁcation for Survivorship Resources Using Clinical Oncology Pathways

08/23/2024

Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...

Manual electronic health records...

08/23/2024

Journal of Clinical Pathways

Abstracts

Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network

08/23/2024

Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.

Delays in cancer treatment...

08/23/2024

Journal of Clinical Pathways

Abstracts

Impact of an EHR-Embedded Clinical Decision Support (CDS) Tool on Guideline Adoption: A Retrospective Analysis of Clinician Adaptation to Treatment Intensiﬁcation in Prostate Cancer

08/23/2024

According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...

According to research published...

08/23/2024

Journal of Clinical Pathways

Abstracts

Building an Episode of Care to Reduce Time to Treatment

08/23/2024

When previously identifying causes of delay in cancer treatment, existing workﬂows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...

When previously identifying...

08/23/2024

Journal of Clinical Pathways

Abstracts

Iris: Using a Telehealth Platform to Provide Virtual Supportive Care for Patients in Oncology

08/23/2024

Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...

Telehealth technologies are...

08/23/2024

Journal of Clinical Pathways